收稿日期: 2019-09-24
网络出版日期: 2020-12-13
基金资助
国家自然科学基金(81470956)
赵冬慧 , 李丹阳 , 张帆 , 屈磊 , 张颖 , 王素霞 , 刘刚 . 4例重链或轻重链肾淀粉样变性患者的临床病理特点[J]. 北京大学学报（医学版）, 2020 , 52(6) : 1162 -1165 . DOI: 10.19723/j.issn.1671-167X.2020.06.031
| [1] | Jean DS, Merrill DB, Joel NB, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification international society of amyloidosis 2016 nomenclature guidelines[J]. Amyloid, 2016,23(4):209-213. |
| [2] | Nasr SH, Said SM, Valeri AM, et al. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis[J]. Kidney Int, 2013,83(3):463-470. |
| [3] | Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis[J]. Clin J Am Soc Nephral, 2010,5(12):2180-2187. |
| [4] | 杨林, 李娟, 王建荣, 等. 肾轻重链淀粉样变一例[J]. 中华肾脏病杂志, 2014,30(8):642. |
| [5] | 曾彩虹, 钟永忠, 刘志红. 肾脏重链淀粉样变性[J]. 肾脏病与透析肾移植杂志, 2013,22(3):282-287. |
| [6] | 张璐璐, 张晓雪, 权松霞, 等. 多发性骨髓瘤合并肾轻重链淀粉样变1例报道[J]. 中华实用诊断与治疗杂志, 2016,30(10):1010-1011. |
| [7] | Eulitz M, Weiss DT, Solomon A. Immunoglobulin heavy-chain-associated amyloidosis[J]. Proc Natl Acad Sci USA, 1990,87(17):6542-6546. |
| [8] | Kaplan B, Martin BM, Boykov O, et al. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis[J]. Virchows Arch, 2005,447(4):756-761. |
| [9] | Rubinstein S, Cornell RF, Du L, et al. Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis[J]. Amyloid, 2017,24(3):205. |
| [10] | Picken MM. Non-light-chain immunoglobulin amyloidosis: time to expand or refine the spectrum to include light+heavy chain amyloidosis[J]. Kidney Int, 2013,83(3):353-356. |
| [11] | Safadi S, Saad A, Quint PS, et al. Disappearance of immuno-globulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis[J]. Nephrol Dial Transplant, 2015,30(7):1151-1155. |
| [12] | Hassoun Y, Kharfandabaja MA, Baz R. Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response[J]. Hematol Oncol Stem Cell Ther, 2015,8(3):138-139. |
| [13] | Laura M. Dember amyloidosis-associated kidney disease[J]. J Am Soc Nephrol, 2006,17(12):3458-3471. |
/
| 〈 |
|
〉 |
